LIVECAST Markets Briefs Calendar

Research

News Search AI Market Assistant Charts & News Instrument directory Macro Politics Prediction Markets News Archive

LIVECAST Markets

☀◐Theme

Menu

Home LIVECAST Markets Briefs Calendar News Search AI Market Assistant Charts & News Instrument directory Macro Politics Prediction Markets News Archive Account

Live News EQUITY FLASH M impact Oct 05, 2026, 11:50 PM UTC

NASDAQ TRADE HALT CONTINUES

SquawkNews Desk

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

UCFI.O

Related stories

Nikkei Rises 0.4% Led by Electronics, Financial Stocks Japanese stocks advanced, with the Nikkei index up 0.4%, as concerns over rising energy costs eased due to a decline in crude oil prices. Gains were primarily driven by the electro M impact | EQUITY | Oct 06, 2026, 12:23 AM UTC New World Development seeks to extend debt maturities with bond exchange offer New World Development asked bondholders to swap debt due in 2027 and 2028 for new notes maturing in 2032, aiming to extend its repayment schedule and improve liquidity. A new unit M impact | EQUITY | Oct 06, 2026, 12:20 AM UTC South Korea's Kospi Reverses Opening Gain South Korea's Kospi index reversed its opening gains and was last seen 0.2% lower at 6988.50. M impact | EQUITY | Oct 06, 2026, 12:16 AM UTC Spyre Therapeutics prices offering of 4,117,648 shares at $85 for about $350 million Spyre Therapeutics priced an underwritten public offering of 4,117,648 common shares at USD 85.00 each, expecting about USD 350 million gross proceeds. Underwriters have a 30-day o M impact | EQUITY | Oct 06, 2026, 12:15 AM UTC KKR to acquire Gen II in $5.1 billion deal KKR is set to purchase Gen II Fund Services, a private capital fund administrator, for $5.1 billion, which includes debt. This acquisition will expand KKR's reach into infrastructu H impact | EQUITY | Oct 06, 2026, 12:15 AM UTC Spyre Therapeutics Prices $350 Million Common Stock Offering Spyre Therapeutics Inc. announced the pricing of its public offering of common stock, raising $350.0 million. M impact | EQUITY | Oct 06, 2026, 12:15 AM UTC

SQUAWK/NEWS

Independent financial newsroom. Editorial expertise and proprietary AI. Paid LiveCast brings live headlines, chart context and priority audio to your trading day. Free research tools remain available.

LiveCast passes from $15 · Institutional API access.

Start LiveCast

News & Research

Open LiveCast
Session Briefs
Macro
Politics
Prediction Markets
News Archive

Markets & Tools

Charts & News
Markets Overview
US Stocks
Market Movers
Economic Calendar
Policy Calendar
AI Market Assistant
News Search
Instrument Directory

Guides

Charts & News Guide
How LiveCast Works
What Is an Audio Squawk?
Why News Moves Markets
News for Traders
How to Trade the News

Plans & API

Plans & Pricing
Institutional API
RSS Feed

Company

About
Why SquawkNews
Newsroom
Editorial Standards
Corrections
Contact us

© 2026 SquawkNews

Privacy Policy Terms of Use

SquawkNews publishes market information and context. It does not provide investment advice or trade recommendations.